Epithelial transport of deoxynivalenol: Involvement of human P-glycoprotein (ABCB1) and multidrug resistance-associated protein 2 (ABCC2)

Food and Chemical Toxicology

Volumn 45, Issue 10, 2007, Pages 1938-1947

  Videmann, Bernadette ^a   Tep, Jonathan ^a   Cavret, Séverine ^a   Lecoeur, Sylvaine ^a  

^a CEMAGREF   (France)

Author keywords

Deoxynivalenol; Epithelial cells; Intestinal transfer; Multidrug resistance associated protein 2; P Glycoprotein; Trichothecenes

Indexed keywords

GLYCOPROTEIN P INHIBITOR; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; VALSPODAR; VERLUKAST; VOMITOXIN;

ANIMAL CELL; ARTICLE; CELL MEMBRANE TRANSPORT; CELL STRAIN CACO 2; CONCENTRATION RESPONSE; CONTROLLED STUDY; EPITHELIUM; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN FUNCTION; RAT; TOXICOKINETICS; TRANSPORT KINETICS; WILD TYPE;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; CACO-2 CELLS; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOSPORINS; DATA INTERPRETATION, STATISTICAL; DOGS; EPITHELIUM; FLOW CYTOMETRY; HUMANS; LLC-PK1 CELLS; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; PROPIONATES; QUINOLINES; SWINE; TEMPERATURE; TRANSFECTION; TRICHOTHECENES;

ANIMALIA;

EID: 34547810884     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2007.04.011     Document Type: Article

References (56)

1. Allen J.D., van Loevezijn A., Lakhai J.M., van der Valk M., van Tellingen O., Reid G., Schellens J.H.M., Koomen G.J., and Schinkel A.H. Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. Mol. Cancer Therap. 1 (2002) 417-425
2. Anderle P., Niederer E., Rubas W., Hilgendorf C., Spahn-Langguth H., Wunderli-Allenspach H., Merkle H.P., and Langguth P. P-glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: the influence of culturing conditions and drug exposure on P-gp expression levels. J. Pharm. Sci. 87 (1998) 757-762
3. Artursson P., and Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 175 (1991) 880-885
4. Artursson P., Palm K., and Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug. Deliv. 46 (2001) 27-43
5. Avantaggiato G., Havenaar R., and Visconti A. Evaluation of the intestinal absorption of deoxynivalenol and nivalenol by an in vitro gastointestinal model, and the binding efficacy of activated carbon and other adsorbent materials. Food Chem. Toxicol. 42 (2004) 817-824
6. Bailey C., Bryla P., and Malick A. The use of the intestinal epithelial cell culture model, Caco-2, in pharmaceutical development. Adv. Drug Deliv. Rev. 22 (1996) 85-103
7. Berger V., Gabriel A.F., Sergent T., Trouet A., Larondelle Y., and Schneider Y.J. Interaction of ochratoxin A with human intestinal Caco-2 cells: possible implication of a multidrug resistance-associated protein (MRP2). Toxicol. Lett. 140-141 (2003) 465-476
8. Bony S., Carcelen M., Olivier L., and Devaux A. Genotoxicity assessment of deoxynivalenol in the Caco-2 cell line model using the Comet assay. Toxicol. Lett. 166 (2006) 67-76
9. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 7 (1976) 248-254
10. Chantret I., Barbat A., Dussaulx E., Brattain M.G., and Zweibaum A. Epithelial polarity, villin expression, and enterocytic differentiation of cultured human colon carcinoma cells: a survey of twenty cell lines. Cancer Res. 48 (1988) 1936-1942
11. Danicke S., Valenta H., and Doll S. On the toxicokinetics and the metabolism of deoxynivalenol (DON) in the pig. Arch. Anim. Nutr. 58 (2004) 169-180
12. 1 and aminopentol on an in vitro model of intestinal epithelium; the role of P-glycoprotein. Toxicon 45 (2005) 285-291
13. Delie F., and Rubas W. A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limits of the Caco-2 model. Crit. Rev. Therap. Drug. 14 (1997) 221-286
14. Eriksen G.S., Pettersson H., and Lindberg J.E. Absorption, metabolism and excretion of 3-acetyl DON in pigs. Arch. Anim. Nutr. 57 (2003) 335-345
15. Eriksen G.S., and Pettersson H. Toxicological evaluation of trichothecenes in animal feed. Anim. Feed Sci. Technol. 114 (2004) 205-239
16. Evers R., Kool M., van Deemter E., Janssen H., Calafat J., Oomen L.C.J.M., Paulusma C.C., Oude Elferink R.P.J., Baas F., Schinkel A.H., and Borst P. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. J. Clin. Invest. 101 (1998) 1310-1319
17. FAO/WHO Expert Committee on Food Additives, 2001. Safety evaluation of certain mycotoxins in food. World Health Organization, Geneva.
18. Gareis, M., Zimmermann, C., Schothorst, R., Paulsh, W., Vidnes, A., Bergsten, C., Paulsen, B., Brera, C., Miraglia, M., Grossi, S., Debegnach, F., 2003. Collection of occurrence data of Fusarium toxins in food and assessment of dietary intake by the population of EU Member States. Final report of experts participating in Task 3.2.10, April 2003. .
19. 4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance. Biochem. Biophys. Res. Commun. 208 (1995) 345-352
20. Gerk P.M., and Vore M. Regulation of expression of the multidrug resistance-associated protein 2 (MRP2) and its role in drug disposition. J. Pharmacol. Exp. Ther. 302 (2002) 407-415
21. Gotoh Y., Suzuki H., Kinoshita S., Hirohashi T., Kato Y., and Sugiyama Y. Involvement of an organic anion transporter (canalicular multispecific organic anion transporter/multidrug resistance-associated protein 2) in gastrointestinal secretion of glutathione conjugates in rats. J. Pharmacol. Exp. Ther. 292 (2000) 433-439
22. Goyarts T., and Danicke S. Bioavailability of the Fusarium toxin deoxynivalenol (DON) from naturally contaminated wheat for the pig. Toxicol. Lett. 163 (2006) 171-182
23. Hidalgo I.J., Raub T.J., and Borchardt R.T. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96 (1989) 736-749
24. Hidalgo I.J., and Borchardt R.T. Transport of bile acids in a human intestinal epithelial cell line, Caco-2. Biochim. Biophys. Acta 1035 (1990) 97-103
25. Hunder G., Schumann K., Strugala G., Gropp J., Fichtl B., and Forth W. Influence of subchronic exposure to low dietary deoxynivalenol, a trichothecene mycotoxin, on intestinal absorption of nutrients in mice. Food Chem. Toxicol. 29 (1991) 809-814
26. Hunter J., Jepson M.A., Tsuruo T., Simmons N.L., and Hirst B.H. Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. J. Biol. Chem. 268 (1993) 14991-14997
27. Krishna R., and Mayer L.D. Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur. J. Pharm. Sci. 11 (2000) 265-283
28. Kuiper-Goodman T. Mycotoxins: risk assessment and legislation. Toxicol. Lett. 82/83 (1995) 853-859
29. Larsen JC., Hunt J., Perrin I., and Ruckenbauer P. Workshop on trichothecenes with a focus on DON: summary report. Toxicol. Lett. 153 (2004) 1-22
30. Lake B.G., Phillips J.C., Walters D.G., Bayley D.L., Cook M.W., Thomas L.V., Gilbert J., Startin J.R., and Baldwin N.C.P. Studies on the metabolism of deoxynivalenol in the rat. Food Chem. Toxicol. 25 (1987) 589-592
31. Leblanc J., Tard A., Volatier J., and Verger P. Estimated dietary exposure to principal food mycotoxins from the first French Total Diet Study. Food Addit. Contam. 22 (2005) 652-672
32. Lee C.H. Reversing agents for ATP-binding cassette (ABC) transporters: application in modulating multidrug resistance (MDR). Curr. Med. Chem.-Anti-Cancer Agents 4 (2004) 43-52
33. MacDonald H.R., and Koch C.J. Energy metabolism and T-cell-mediated cytolysis. J. Exp. Med. 146 (1977) 698-709
34. Maeng H.J., Yoo H.J., Kim I.W., Song I.S., Chung S.J., and Shim C.K. P-Glycoprotein-mediated transport of berberine across Caco-2 cell monolayers. J. Pharm. Sci. 91 (2002) 2614-2621
35. Makhey V.D., Guo A., Norris D.A., Hu P., Yan J., and Sinko P.J. Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells. Pharm. Res. 15 (1998) 1160-1167
36. Meky F.A., Turner P.C., Ashcroft A.E., Miller J.D., Qiao Y.-L., Roth M.J., and Wild C.P. Development of a urinary biomarker of human exposure to deoxynivalenol. Food Chem. Toxicol. 41 (2003) 265-273
37. Pestka J.J., and Smolinsky A.T. Deoxynivalenol: toxicology and potential effects on humans. J. Toxicol. Environ. Health B Crit. Rev. 8 (2005) 39-69
38. Pinto M., Robine-Leon S., Appay M.D., Kedinger M., Triadou N., Dussaulx E., Lacroix B., Simon-Assmann P., Haffen K., Fogh J., and Zweibaum A. Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol. Cell 47 (1983) 323-330
39. Prelusky D.B., Trenholm H.L., Lawrence G.A., and Scott P.M. Nontransmission of deoxynivalenol (vomitoxin) to milk following oral administration to dairy cows. J. Environ. Sci. Health 19 (1984) 593-609
40. Prelusky D.B., Hamilton R.M., Trenholm H.L., and Miller J.D. Tissue distribution and excretion of radioactivity following administration of 14C labelled deoxynivalenol to White Leghorn hens. Fund. Appl. Toxicol. 7 (1986) 635-645
41. Prelusky D.B., Veira D.M., Trenholm H.L., and Hartin K.E. Excretion profiles of the mycotoxin deoxynivalenol, following oral and intravenous administration to sheep. Fund. Appl. Toxicol. 6 (1986) 356-363
42. Prelusky D.B., Hartin K.E., Trenholm H.L., and Miller J.D. Pharmacokinetic fate of 14C-labeled deoxynivalenol in swine. Fund. Appl. Toxicol. 10 (1988) 276-286
43. Rotter B.A., Prelusky D.B., and Pestka J.J. Toxicology of deoxynivalenol (vomitoxin). J. Toxicol. Environ. Health 48 (1996) 1-34
44. Ruiz-Garcia A.R., Lin H., Pla-Delfina J.M., and Hu M. Kinetic characterization of secretory transport of a new ciprofloxacin derivative (CN97100) across Caco-2 cell monolayers. J. Pharm. Sci. 91 (2002) 2511-2519
45. Schinkel A.H., Wagenaar E., van Deemter L., Mol C.A.A.M., and Borst P. Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J. Clin. Invest. 96 (1995) 1698-1705
46. Schinkel A.H., and Jonker J.W. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv. Drug Deliv. Rev. 55 (2003) 3-29
47. Schrickx J., Lektarau K., and Fink-Gremmels J. Ochratoxin A secretion by ATP-dependent membrane transporters in Caco-2 cells. Arch. Toxicol. 80 (2006) 243-249
48. Sergent T., Garsou S., Schaut A., De Saeger S., Pussemier L., van Peteghem C., Larondelle Y., and Schneider Y.J. Differential modulation of ochratoxin A absorption across Caco-2 cells by dietary polyphenols, used at realistic intestinal concentrations. Toxicol. Lett. 159 (2005) 60-70
49. Sergent T., Parys M., Garsou S., Pussemier L., Schneider Y.J., and Larondelle Y. Deoxynivalenol transport across human intestinal Caco-2 cells and its effects on cellular metabolism at realistic intestinal concentrations. Toxicol. Lett. 164 (2006) 167-176
50. Sundstol-Eriksen G., and Pettersson H. Lack of de-epoxidation of type B trichothecenes in incubates with human faeces. Food Addit. Contam. 20 (2003) 579-582
51. Taipalensuu J., Törnblom H., Lindberg G., Einarsson C., Sjökvist F., Melhus H., Garberg P., Sjöström B., Lundgren B., and Artursson P. Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. J. Pharmacol. Exp. Ther. 299 (2001) 164-170
52. Takano M., Yumoto R., and Murakami T. Expression and function of efflux drug transporters in the intestine. Pharmacol. Ther. 109 (2006) 137-161
53. Wacher V.J., Salphati L., and Benet L.Z. Active secretion and enterocytic drug metabolism barriers to drug absorption. Adv. Drug Deliv. Rev. 46 (2001) 89-102
54. Walker F., and Meier B. Determination of the Fusarium mycotoxins nivalenol, deoxynivalenol, 3-acetyldeoxynivalenol, and 15-O-acetyl-4-deoxynivalenol in contaminated whole wheat flour by liquid chromatography with diode array detection and gas chromatography with electron capture detection. J. AOAC Int. 81 (1998) 741-748
55. Wolf-Hall C.E., and Schwartz P.B. Mycotoxins and fermentation-beer production. Adv. Exp. Med. Biol. 504 (2002) 217-226
56. Young J.C., Fulcher R.G., Hayhoe J.H., Scott P.M., and Dexter J.E. Effect of milling and baking on deoxynivalenol (vomitoxin) content of Eastern Canadian wheats. J. Agric. Food Chem. 32 (1984) 659-664